CLARO T PALMA

Allopathic & Osteopathic Physicians|Internal Medicine|Rheumatology ELLIJAY, GA NPI 1679527063

General Payments — all program years on this page

$756.26

  • Category: General Payments
  • Program years: PY2022–2024
  • Record count: 33
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $257.76 across 14 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $219.2612
Education $38.502

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Amgen Inc. $70.814
NOVARTIS PHARMACEUTICALS CORPORATION $63.254
UCB, Inc. $44.092
SOBI, INC $38.502
Janssen Biotech, Inc. $23.151
GlaxoSmithKline, LLC. $17.961

By program year

Program yearAmountRecords
2022 $259.3110
2023 $239.199
2024 $257.7614

Records — PY2024 (14)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078538109 Janssen Biotech, Inc. $23.15 08/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087227749 Novartis Pharmaceuticals Corporation $18.11 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087227751 Novartis Pharmaceuticals Corporation $15.18 05/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087227781 Novartis Pharmaceuticals Corporation $15.21 11/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087227787 Novartis Pharmaceuticals Corporation $14.75 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111668538 Amgen Inc. $21.09 04/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111668540 Amgen Inc. $16.88 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116697171 GlaxoSmithKline, LLC. $17.96 06/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117648063 Amgen Inc. $18.25 12/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117648065 Amgen Inc. $14.59 12/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141421129 SOBI, INC $19.25 05/22/2024 Education Undisputed 01/23/2026 View at CMS
1141425209 SOBI, INC $19.25 09/19/2024 Education Undisputed 01/23/2026 View at CMS
1143353006 UCB, Inc. $20.04 07/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143353011 UCB, Inc. $24.05 10/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.